These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 20425465)
1. Beyond rituximab: The future of monoclonal antibodies in B-cell non-Hodgkin lymphoma. Sikder MA; Friedberg JW Curr Hematol Malig Rep; 2008 Oct; 3(4):187-93. PubMed ID: 20425465 [TBL] [Abstract][Full Text] [Related]
2. Beyond rituximab: the future of monoclonal antibodies in B-cell non-Hodgkin lymphoma. Sikder MA; Friedberg JW Curr Oncol Rep; 2008 Sep; 10(5):420-6. PubMed ID: 18706270 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody therapy for lymphoma. Campbell P; Marcus R Blood Rev; 2003 Sep; 17(3):143-52. PubMed ID: 12818224 [TBL] [Abstract][Full Text] [Related]
4. CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma. Cruz RI; Hernandez-Ilizaliturri FJ; Olejniczak S; Deeb G; Knight J; Wallace P; Thurberg BL; Kennedy W; Czuczman MS Leuk Lymphoma; 2007 Dec; 48(12):2424-36. PubMed ID: 18067019 [TBL] [Abstract][Full Text] [Related]
5. The future of CD20 monoclonal antibody therapy in B-cell malignancies. Czuczman MS; Gregory SA Leuk Lymphoma; 2010 Jun; 51(6):983-94. PubMed ID: 20367564 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies in the treatment of cancer, Part 1. Cersosimo RJ Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753 [TBL] [Abstract][Full Text] [Related]
7. [Proteins in haematology]. Clarenbach RE; Mey U Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody therapy of leukaemias and lymphomas. Jacobs SA; Foon KA Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma. Betting DJ; Yamada RE; Kafi K; Said J; van Rooijen N; Timmerman JM J Immunother; 2009; 32(6):622-31. PubMed ID: 19483647 [TBL] [Abstract][Full Text] [Related]
13. Innovative strategies in lymphoma therapy. Jäger U Wien Klin Wochenschr; 2003 Aug; 115(13-14):462-70. PubMed ID: 13677264 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy combinations with monoclonal antibodies in non-Hodgkin's lymphoma. Kahl B Semin Hematol; 2008 Apr; 45(2):90-4. PubMed ID: 18381103 [TBL] [Abstract][Full Text] [Related]
15. Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab. Sacchi S; Federico M; Dastoli G; Fiorani C; Vinci G; Clò V; Casolari B Crit Rev Oncol Hematol; 2001 Jan; 37(1):13-25. PubMed ID: 11164715 [TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies in hematology in 2009]. Bonnet C; Beguin Y; De Prijck B; Witvrouw N; Hustinx R; Fillet G Rev Med Liege; 2009; 64(5-6):268-73. PubMed ID: 19642457 [TBL] [Abstract][Full Text] [Related]
17. Antibody-based therapy of non-Hodgkin's lymphoma. Foran JM Best Pract Res Clin Haematol; 2002 Sep; 15(3):449-65. PubMed ID: 12468399 [TBL] [Abstract][Full Text] [Related]
18. Rituximab therapy of B-cell neoplasms. Petryk M; Grossbard ML Clin Lymphoma; 2000 Dec; 1(3):186-94; discussion 195-6. PubMed ID: 11707828 [TBL] [Abstract][Full Text] [Related]
19. [Clinical use of monoclonal antibodies in malignant lymphomas]. Schnell R; Hiddemann W; Diehl V; Engert A Internist (Berl); 2001 Jun; 42(6):815-6, 819-26. PubMed ID: 11449628 [No Abstract] [Full Text] [Related]
20. [Monoclonal antibody treatment of malignant lymphoma]. Buske C; Dreyling M; Unterhalt M; Hiddemann W Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]